Loading...
Dynavax Technologies Corporation
DVAX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$11.36
$0.20(1.79%)
Dynavax Technologies Corporation (DVAX) Financial Performance & Income Statement Overview
Review Dynavax Technologies Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
19.36%
↑ 19.36%
Operating Income Growth
88.87%
↑ 88.87%
Net Income Growth
527.44%
↑ 527.44%
Operating Cash Flow Growth
-33.86%
↓ 33.86%
Operating Margin
-3.10%
↓ 3.10%
Gross Margin
82.27%
↑ 82.27%
Net Profit Margin
-20.39%
↓ 20.39%
ROE
-9.80%
↓ 9.80%
ROIC
-1.04%
↓ 1.04%
Dynavax Technologies Corporation (DVAX) Income Statement & Financial Overview
Review Dynavax Technologies Corporation's (DVAX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $72.03M | $80.63M | $73.80M | $50.79M |
| Cost of Revenue | $13.41M | $13.08M | $11.98M | $10.97M |
| Gross Profit | $58.62M | $67.55M | $61.81M | $39.82M |
| Gross Profit Ratio | $0.81 | $0.84 | $0.84 | $0.78 |
| R&D Expenses | $18.67M | $14.40M | $14.95M | $13.53M |
| SG&A Expenses | $41.59M | $43.06M | $40.80M | $42.88M |
| Operating Expenses | $60.25M | $57.46M | $55.75M | $56.40M |
| Total Costs & Expenses | $73.66M | $70.55M | $67.73M | $67.37M |
| Interest Income | $8.41M | $9.38M | $9.20M | $9.47M |
| Interest Expense | $1.70M | $1.41M | $1.41M | $1.41M |
| Depreciation & Amortization | $2.07M | $2.05M | $1.98M | $1.95M |
| EBITDA | $11.40M | $10.08M | $18.58M | -$7.85M |
| EBITDA Ratio | $0.16 | $0.13 | $0.25 | -$0.15 |
| Operating Income | -$1.63M | $10.08M | $6.06M | -$16.58M |
| Operating Income Ratio | -$0.02 | $0.13 | $0.08 | -$0.33 |
| Other Income/Expenses (Net) | $9.26M | $9.74M | $8.85M | $5.08M |
| Income Before Tax | $7.63M | $19.82M | $14.91M | -$11.50M |
| Income Before Tax Ratio | $0.11 | $0.25 | $0.20 | -$0.23 |
| Income Tax Expense | $579000.00 | $2.22M | $3.52M | -$2.78M |
| Net Income | $7.05M | $17.59M | $11.39M | -$8.72M |
| Net Income Ratio | $0.10 | $0.22 | $0.15 | -$0.17 |
| EPS | $0.06 | $0.13 | $0.09 | -$0.07 |
| Diluted EPS | $0.05 | $0.11 | $0.08 | -$0.07 |
| Weighted Avg Shares Outstanding | $127.95M | $131.13M | $130.92M | $130.20M |
| Weighted Avg Shares Outstanding (Diluted) | $153.02M | $154.81M | $154.47M | $130.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan